News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>UBS Lowers SAMSONITE's TP to HKD15.3; Rating Kept Neutral
According to a UBS research report, SAMSONITE (01910.HK) is set to announce its 2Q25 results next month, which the broker predicted to largely meet expectations.In UBS' estimat...
Reset
Send
The window will close in 5 seconds
<Research>UBS Lowers SAMSONITE's TP to HKD15.3; Rating Kept Neutral
Close
Recommend
6
Positive
7
Negative
7
 
 

According to a UBS research report, SAMSONITE (01910.HK)  +0.320 (+2.116%)    Short selling $15.17M; Ratio 22.963%   is set to announce its 2Q25 results next month, which the broker predicted to largely meet expectations.

In UBS' estimates, SAMSONITE's sales will decline by 4.6% at constant exchange rates, similar to 1Q25, while its GPM will remain at around 59%, reflecting minimal impact from tariffs as the group has prepared inventory in advance. The company's adjusted EBITDA for 2Q is expected to be USD145 million.

UBS also projected that SAMSONITE's revenue and profit in 2H would hinge on tariff rates and consumer confidence in various markets. Its conservative estimate was that the revenue decline in 2H would be deeper than in 1H.

For the full year, SAMSONITE's revenue is forecasted to decrease by 6% YoY, while its adjusted EBITDA margin will ebb by 310 bps to 15.9%.

UBS reduced its target price from HKD16.3 to HKD15.3 and kept the Neutral rating unchanged.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-04 16:25.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.